Funding Received
$45 Million in 1 Round from 7 Investors
Most Recent Funding
$45 Million on May 20, 2013 / Undisclosed Round
Headquarters:
San Diego, CA
Description:
Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.
Categories:
Biotechnology
Website:
http://effector.com

Company Details

Update

eFFECTOR Therapeutics is an early stage company focused on the discovery and development of new small molecule cancer therapeutics. eFFECTOR is developing translation regulators to selectively block disregulated translation impacting tumor growth and survival. The company has selected control of mRNA translation as a key point of theerapeutic intervention, providing potency and selectivity while inhibiting growth of cancer cells. eFFECTOR's novel approach provides a real opportunity to bring innovative new medicines to patients in need.

Board Members and Advisors (2)

Update

Investors (7)

Update

Offices/Locations (1)

Update
  • Office

    11180 Roselle Street

    San Diego, CA 92121

    USA

Images (1)

Update
  • 2f377cf0c2f00d7dc15a38bbe7848f24